- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 35/545 - Embryonic stem cells; Pluripotent stem cells; Induced pluripotent stem cells; Uncharacterised stem cells
Patent holdings for IPC class A61K 35/545
Total number of patents in this class: 1326
10-year publication summary
|
109
|
97
|
148
|
142
|
116
|
136
|
118
|
137
|
119
|
0
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| The Regents of the University of California | 19479 |
43 |
| Tohoku University | 2677 |
33 |
| Kyoto University | 2778 |
30 |
| FATE Therapeutics, Inc. | 186 |
25 |
| Life Science Institute, Inc | 65 |
23 |
| Osaka University | 3288 |
20 |
| President and Fellows of Harvard College | 5904 |
19 |
| Healios K.K. | 92 |
17 |
| Sumitomo Pharma Co., Ltd. | 633 |
17 |
| The Board of Trustees of the Leland Stanford Junior University | 6226 |
15 |
| CRISPR Therapeutics AG | 364 |
14 |
| Memorial Sloan-Kettering Cancer Center | 1883 |
13 |
| Riken | 1684 |
12 |
| Minovia Therapeutics Ltd. | 51 |
11 |
| University of Washington | 2241 |
11 |
| Sumitomo Dainippon Pharma Co., Ltd. | 220 |
10 |
| ViaCyte, Inc. | 179 |
10 |
| Sumitomo Chemical Company, Limited | 8966 |
9 |
| The Johns Hopkins University | 5519 |
9 |
| CorMatrix Cardiovascular, Inc. | 180 |
9 |
| Other owners | 976 |